Diagnostic Findings in 95 Finnish Patients with Common Variable Immunodeficiency (original) (raw)

REFERENCES

  1. International Union of Immunological Societies: Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. Clin Exp Immunol 118(Suppl 1):1–28, 1999
    Google Scholar
  2. Saiki O, Ralph P, Cunningham-Rundles C, Good RA: Three distinct stages of B-cell defects in common varied immunodeficiency. Proc Natl Acad Sci USA 79:6008–6012, 1982
    Google Scholar
  3. Eskola J, Savilahti E, Nikoskelainen J, Ruuskanen O: Regulatory T-cell function in primary humoral immunodeficiency states. J Clin Lab Immunol 28:55–60, 1989
    Google Scholar
  4. Bryant A, Calver NC, Toubi E, Webster AD, Farrant J: Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin Immunol Immunopathol 56:239–248, 1990
    Google Scholar
  5. Pastorelli G, Roncarolo MG, Touraine JL, Rousset F, Pene J, de Vries JE: Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones. Clin Exp Immunol 78:341–347, 1989
    Google Scholar
  6. Spickett GP, Webster AD, Farrant J: Cellular abnormalities in common variable immunodeficiency. Immunodefic Rev 2:199–219, 1990
    Google Scholar
  7. Sneller MC, Strober W: Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency. J Immunol 144:3762–3769, 1990
    Google Scholar
  8. Punnonen J, Kainulainen L, Ruuskanen O, Nikoskelainen J, Arvilommi H: IL-4 synergizes with IL-10 and anti-CD40 MoAbs to induce B-cell differentiation in patients with common variable immunodeficiency. Scand J Immunol 45:203–212, 1997
    Google Scholar
  9. Cunningham-Rundles C: Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 9:22–33, 1989
    Google Scholar
  10. Cunningham-Rundles C, Bodian C: Common variable immunode-ficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48, 1999
    Google Scholar
  11. Webster AD: Virus infections in primary immunodeficiency. J Clin Pathol 47:965–967, 1994
    Google Scholar
  12. Hausser C, Virelizier JL, Buriot D, Griscelli C: Common variable hypogammaglobulinemia in children. Clinical and immunologic observations in 30 patients. Am J Dis Child 137:833–837, 1983
    Google Scholar
  13. Hermans PE, Diaz-Buxo JA, Stobo JD: Idiopathic late-onset immunoglobulin deficiency. Clinical observations in 50 patients. Am J Med 61:221–237, 1976
    Google Scholar
  14. Hermaszewski RA, Webster AD: Primary hypogammaglobulinaemia: A survey of clinical manifestations and complications. Q J Med 86:31–42, 1993
    Google Scholar
  15. Blore J, Haeney MR: Primary antibody deficiency and diagnostic delay. BMJ 298:516–517, 1989
    Google Scholar
  16. Roifman CM, Levison H, Gelfand EW: High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet 1:1075–1077, 1987
    Google Scholar
  17. Gelfand EW, Reid B, Roifman CM: Intravenous immune serum globulin replacement in hypogammaglobulinemia. A comparison of high-versus low-dose therapy. Monogr Allergy 23:177–186, 1988
    Google Scholar
  18. Liese JG, Wintergerst U, Tympner KD, Belohradsky BH: High-vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia. Am J Dis Child 146:335–339, 1992
    Google Scholar
  19. Kinlen LJ, Webster AD, Bird AG, et al.: Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet 1:263–266, 1985
    Google Scholar
  20. Cunningham-Rundles C, Siegal FP, Cunningham Rundles S, Lieberman P: Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol 7:294–299, 1987
    Google Scholar
  21. Mueller BU, Pizzo PA: Cancer in children with primary or secondary immunodeficiencies. J Pediatr 126:1–10, 1995
    Google Scholar
  22. Eisenstein EM, Sneller MC: Common variable immunodeficiency: diagnosis and management. Ann Allergy 73:285–292, 1994
    Google Scholar
  23. Vetrie D, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F, Hammarström L, Kinnon C, Levinsky R, Bobrow M, Smith CIE, Bentley DR: The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361:226–233, 1993
    Google Scholar
  24. Ochs HD, Smith CI: X-linked agammaglobulinemia. A clinical and molecular analysis. Medicine 75:287–299, 1996
    Google Scholar
  25. Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, Roberts RL, Noelle RJ, Ledbetter JA, Francke U, Ochs HD: The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291–300, 1993
    Google Scholar
  26. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Reznick I, Fasth A, Baer M, Gomez L, Sanders EAM, Tahone M-D, Plantaz D, Etzioni A, Monafo V, Hammarstrst\(\ddot o\ddot m\) L, Abrahamsen T, Jones A, Finn A, Klemola T, De Vries E, Sanal O, Petisch MC, Notarangelo LD: Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 131:47–54, 1997
    Google Scholar
  27. Kainulainen L, Varpula M, Liippo K, Svedstro¨m E, Nikoskelainen J, Ruuskanen O: Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 104:1031–1036, 1999
    Google Scholar
  28. Fasth A: Primary immunodeficiency disorders in Sweden: Cases among children, 1974–1979. J Clin Immunol 2:86–92, 1982
    Google Scholar
  29. Kainulainen L, Nikoskelainen J, Vuorinen T, Tevola K, Liippo K, Ruuskanen O: Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia. Am J Respir Crit Care Med 159:1199–204, 1999
    Google Scholar

Download references